ENTA
Enanta Pharmaceuticals Inc
10.70$
-3.9%
vs. previous close
Closing price · As of: Oct 30, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Enanta Pharmaceuticals Inc (ENTA) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 10/29/2026 | Current report (8-K) | ENANTA PHARMACEUTICALS INC (ENTA): Other Events | View report ↗ |
| 10/28/2026 | Current report (8-K) | ENANTA PHARMACEUTICALS INC (ENTA): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure; Financial Statements and Exhibits | View report ↗ |
| 08/10/2026 | Current report (8-K) | ENANTA PHARMACEUTICALS INC (ENTA): Results of Operations and Financial Condition; Financial Statements and Exhibits | View report ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.